RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Yourgene Health Stock

Yourgene Health Stocks 2024

Yourgene Health Stocks

724.25 M

Ticker

YGEN.L

ISIN

GB00BN31ZD89

WKN

A116JH

In 2024, Yourgene Health had 724.25 M outstanding stocks, a 0% change from the 724.25 M stocks in the previous year.

The Yourgene Health Stocks history

YEARNUMBER OF STOCKS (undefined GBP)
2027e724.25
2026e724.25
2025e724.25
2024e724.25
2023e724.25
2022724.25
2021685.64
2020590.47
2019399.64
2018321.22
2017236.28
2016218.11
2015148.95
201421.99
201313.31
201211.02
201110.09
20108.8
20097.03
20086.45
20075.07
20064.44
20054.32
20043.72
20033.5

Yourgene Health shares outstanding

The number of shares was Yourgene Health in 2023 — This indicates how many shares 724.248 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Yourgene Health earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Yourgene Health's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Yourgene Health’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Yourgene Health's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Yourgene Health Aktienanalyse

What does Yourgene Health do?

Yourgene Health PLC is an international life science company specializing in the development and marketing of DNA tests for various areas of health. The company, based in Manchester, England, was founded in 2009 and has been listed on the London Stock Exchange since 2013. The business model of Yourgene Health is to offer genetic tests for a variety of applications in order to improve people's well-being, health, and quality of life. The company has extensive experience in developing DNA diagnostic tests and offers a wide range of solutions for different markets. One of the core divisions of the company is oncology. Here, Yourgene Health PLC develops innovative test methods to identify and combat cancer cells and their growth. Another important area is reproductive health, where the company offers prenatal testing as well as fertility analysis. In Yourgene Health's broad product range, there are prenatal tests for the examination of chromosomal abnormalities in the fetus, tests for the analysis of genetic risks for hereditary diseases or thyroid diseases. The company also offers tests for the detection of bacteria and viruses, which serve as companion tests for infections. One of Yourgene Health's newest products is the Covid-19 PCR test. This test is performed through nasal and throat swabs and can provide an accurate diagnosis of coronavirus infection within a few hours. The test was developed in 2020 and has since proven to be an important measure in containing the pandemic along the test-trace-isolate model. In recent years, Yourgene Health has made numerous collaborations and acquisitions to strengthen its market position in different countries. This includes the acquisition of the US company Elucigene Diagnostics, a provider of DNA test solutions for reproductive health, in 2021. As part of its growth strategy, the company has announced expansion plans for Asia, particularly for China and Japan. For this purpose, the subsidiary Yourgene Health Shanghai was established in 2019. Yourgene Health PLC is an innovative company operating in a rapidly growing market. Through continuous development of new innovative test methods, implementation of collaborations and acquisitions, and expansion into new markets, the company is well positioned to achieve further growth successes and improve global health for consumers. Yourgene Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Yourgene Health's Shares Outstanding

Yourgene Health's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Yourgene Health’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Yourgene Health’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Yourgene Health’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Yourgene Health stock

How many stocks are there of Yourgene Health?

The current number of stocks of Yourgene Health is 724.25 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Yourgene Health are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Yourgene Health evolved in recent years?

The number of shares of Yourgene Health has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Yourgene Health as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Yourgene Health?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Yourgene Health pay?

Over the past 12 months, Yourgene Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Yourgene Health is expected to pay a dividend of 0 GBP.

What is the dividend yield of Yourgene Health?

The current dividend yield of Yourgene Health is .

When does Yourgene Health pay dividends?

Yourgene Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Yourgene Health?

Yourgene Health paid dividends every year for the past 0 years.

What is the dividend of Yourgene Health?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Yourgene Health located?

Yourgene Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Yourgene Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Yourgene Health from 10/2/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Yourgene Health pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of Yourgene Health in the year 2023?

In the year 2023, Yourgene Health distributed 0 GBP as dividends.

In which currency does Yourgene Health pay out the dividend?

The dividends of Yourgene Health are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Yourgene Health stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Yourgene Health

Our stock analysis for Yourgene Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Yourgene Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.